HUP0400767A2 - Javított eljárás tiszta ondansetron-hidroklorid-dihidrát előállítására - Google Patents

Javított eljárás tiszta ondansetron-hidroklorid-dihidrát előállítására

Info

Publication number
HUP0400767A2
HUP0400767A2 HU0400767A HUP0400767A HUP0400767A2 HU P0400767 A2 HUP0400767 A2 HU P0400767A2 HU 0400767 A HU0400767 A HU 0400767A HU P0400767 A HUP0400767 A HU P0400767A HU P0400767 A2 HUP0400767 A2 HU P0400767A2
Authority
HU
Hungary
Prior art keywords
improved process
hydrochloride dihydrate
ondansetron hydrochloride
preparing pure
pure ondansetron
Prior art date
Application number
HU0400767A
Other languages
English (en)
Inventor
Eliezer Bachar
Ramy Lidor Hadas
Original Assignee
Teva Pharmaceutical Industries Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Limited filed Critical Teva Pharmaceutical Industries Limited
Publication of HUP0400767A2 publication Critical patent/HUP0400767A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)

Abstract

A találmány tárgya javított eljárás dimetil-amino-metil-karbazolon ésondansetron előállítására. A találmány tárgya tavábbá egyátkristályosítási eljárás tiszta ondansetronhidorklorid-dihidrátelőállítására, amelynek tisztasága legalább 99,0%-os. Ó
HU0400767A 2001-01-11 2002-01-11 Javított eljárás tiszta ondansetron-hidroklorid-dihidrát előállítására HUP0400767A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26105201P 2001-01-11 2001-01-11
PCT/US2002/000853 WO2002055492A2 (en) 2001-01-11 2002-01-11 An improved process for preparing pure ondansetron hydrochloride dihydrate

Publications (1)

Publication Number Publication Date
HUP0400767A2 true HUP0400767A2 (hu) 2004-07-28

Family

ID=22991757

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0400767A HUP0400767A2 (hu) 2001-01-11 2002-01-11 Javított eljárás tiszta ondansetron-hidroklorid-dihidrát előállítására

Country Status (21)

Country Link
EP (1) EP1355881A4 (hu)
JP (1) JP2004526692A (hu)
KR (3) KR20030068583A (hu)
CN (2) CN1496350A (hu)
AU (1) AU2002236753B2 (hu)
CA (1) CA2433720A1 (hu)
CZ (1) CZ20032090A3 (hu)
DE (1) DE02703115T1 (hu)
ES (1) ES2219201T1 (hu)
HR (1) HRP20030631A2 (hu)
HU (1) HUP0400767A2 (hu)
IL (1) IL156835A0 (hu)
IS (1) IS6869A (hu)
MX (1) MXPA03006215A (hu)
NO (1) NO20033147L (hu)
PL (1) PL368837A1 (hu)
SK (1) SK9892003A3 (hu)
TR (1) TR200401460T3 (hu)
WO (1) WO2002055492A2 (hu)
YU (1) YU56103A (hu)
ZA (1) ZA200305338B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040104654A (ko) 2002-04-29 2004-12-10 비오갈 기오기스제르갸르 알티. 1,2,3,9-테트라히드로-9-메틸-3-[(2-메틸-1ｈ-이미다졸-1-일)메틸]-4ｈ-카르바졸-4-온의 제조 방법
HU225885B1 (en) * 2002-10-17 2007-11-28 Richter Gedeon Nyrt Process for producing ondansetron hydrochlorid dihydrate of high purity
FI6164U1 (fi) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronmuotoja
GB2398071B (en) * 2003-01-24 2006-06-07 Synthon Bv Process for making ondansetron and intermediate thereof
US7696356B2 (en) 2004-08-17 2010-04-13 Taro Pharmaceutical Industries Limited Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom
EP1828141A4 (en) * 2004-10-26 2009-04-01 Ipca Lab Ltd STAINING METHOD FOR PREPARING THE ANTIEMETIC 1,2,3,9-TETRAHYDRO-9-METHYL-3 - [(2-METHYL) -1H-IMIDAZOLE-1-YL) METHYL] -4H-CARBAZOLE-4-ON

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
CA2426026A1 (en) * 2000-10-30 2002-05-10 Judith Aronhime Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation

Also Published As

Publication number Publication date
IS6869A (is) 2003-07-08
AU2002236753B2 (en) 2007-06-28
TR200401460T3 (hu) 2004-08-23
HRP20030631A2 (en) 2005-06-30
CN1496350A (zh) 2004-05-12
ZA200305338B (en) 2004-07-12
KR20030068583A (ko) 2003-08-21
MXPA03006215A (es) 2005-02-17
WO2002055492A3 (en) 2003-02-13
CN101045704A (zh) 2007-10-03
DE02703115T1 (de) 2004-10-21
KR20070054749A (ko) 2007-05-29
CA2433720A1 (en) 2002-07-18
CZ20032090A3 (cs) 2004-08-18
JP2004526692A (ja) 2004-09-02
PL368837A1 (en) 2005-04-04
NO20033147L (no) 2003-09-02
EP1355881A2 (en) 2003-10-29
SK9892003A3 (en) 2004-05-04
KR20060113792A (ko) 2006-11-02
IL156835A0 (en) 2004-02-08
WO2002055492A2 (en) 2002-07-18
ES2219201T1 (es) 2004-12-01
NO20033147D0 (no) 2003-07-09
EP1355881A4 (en) 2004-03-31
YU56103A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
MXPA02012795A (es) Carvedilol.
WO2003104473A3 (de) Galactosyl-isomalt, verfahren zu seiner herstellung und verwendung
CY1109599T1 (el) Κρυσταλλικες μορφες υδροχλωρικης (r)-8-χλωρο-1-μεθυλο-2,3,4,5-τετραϋδρο-1η-3-βενζαζεπινης
IL160440A (en) Dihydropteridinones, method for producing the same and the use thereof as medicaments
HK1089444A1 (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
TW200611692A (en) Processes for preparation of crystalline mycophenolate sodium
NO20062599L (no) Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav
HUP0500753A2 (hu) A valacyclovir-hidroklorid kristályos formái
HK1111168A1 (en) A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6 ß,7ß,15 ß,16 ß - BISMETHYLENE-17a-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Y-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS
SG144736A1 (en) Synthesis of temozolomide and analogs
HUP0200580A2 (hu) Celecoxib polimorf kristályos formái, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
SE9903291D0 (sv) New process
WO2003106450A8 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
HUP0402112A2 (hu) Eljárás kristályos imipenem előállítására
SG143062A1 (en) Synthesis of temozolomide and analogs
RS8604A (en) Process for the production of beraprost and its salts
HUP0400767A2 (hu) Javított eljárás tiszta ondansetron-hidroklorid-dihidrát előállítására
NO20063012L (no) Fremgangsmaten for syntesen av perindopril og farmasoytisk akseptable salter derav
HK1075052A1 (en) Intermediates for lhrh antagonist synthesis, proc ess for their production, and process for lhrh antagonist production
NO20052197L (no) Fremgangsmate for fremstilling av pyrazol
MXPA03006057A (es) Proceso para preparar (+) trans-4-p-fluorofenil -3 hidroximetil.
WO2003106440A3 (en) PROCESS FOR THE SYNTHESIS OF A BENZAMIDE DERIVATIVE
MXPA05003881A (es) Preparacion de compuestos triazospiro.
MXPA04004980A (es) Antagonistas del receptor ccr-3.

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees